ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Janssen announces two-drug combination of dolutegravir and rilpivirine demonstrates efficacy in main
March 06, 2017Positive results of switching patients from a three or four drug antiretroviral regimen to the two-drug regimen of dolutegravir and rilpivirine -
EMA recommends expanded indication for Janssen multiple myeloma drug
February 28, 2017The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of Janssen’s CD38-directed monoclonal antibody Darzalex (daratumumab). -
Renova takes over rights to heart failure candidate stresscopin from Janssen
February 09, 2017US-based Renova Therapeutics has signed an agreement to receive the investigational new drug (IND) file for stresscopin from Janssen Pharmaceuticals. -
Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation o
February 06, 2017Janssen Research & Development has announced several new collaborations through its Janssen Human Microbiome Institute (JHMI) focused on advancing the discovery, development and commercialization of next-generation microbial products.
Pharma Sources Insight January 2025
